-
-
Humanized model of the immune system
-
iHuPBMC-T
-
iHuPBMC-NK
-
iHuPBMC-B
-
PBMC-LT
-
CD34+ HSC
-
Winn model
-
iHuPBMC-MHC/KO
-
iHuPBMC-OncVax
-
PBMC mixed inoculation model
more -
-
In vivo tumor experimental platform
-
CDX
-
iHuPDX
-
Non-GLP Toxicology
-
PK/PD
-
Brain in situ model
-
Other in situ models
-
Hematologic tumor model system inoculation
-
Creation of high interstitial tumor models
more -
-
In vitro killing experiment platform
-
Immune co-culture killing model
-
CDC
-
In vitro killing experiment platform
-
IC50
-
PDC High-Throughput In Vitro Pharmacodynamics
-
3D organoids
-
ADCC
-
T cell-mediated killing experiment
more -
-
Mouse-derived immune system model
more -
Tumor vaccine
more -
Cell therapy
more -
In vitro testing platform
more -
Non-GLP Toxicology Platform
more -
Non-tumor model and drug efficacy evaluation platform
-
Systematic Vaccination Model
-
Non-tumor model and drug efficacy evaluation platform
-
Skin injury model
-
Stroke model
-
Liver fibrosis model
-
Diabetes model
-
Gouty Arthritis (GA) Model
-
Pulmonary fibrosis model
-
Systemic lupus erythematosus (SLE) model
-
Inflammatory Bowel Disease (IBD) model
-
Rheumatoid Arthritis (RA) Model
more -
-
-
-
PDX model
-
PDX model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Human breast cancer
-
Esophageal cancer in humans
-
Human gastric cancer
-
Colorectal cancer
-
Human liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Human pancreatic cancer
-
Human kidney cancer
-
Human Bladder Cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer in women
-
Human Ovarian Cancer
-
Human skin cancer
-
sarcoma
-
Human Nervous System Cancer
-
Embryonal carcinoma
-
Human Lymphoma
-
Human leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other people
more -
-
CDX model
-
CDX model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Human breast cancer
-
Esophageal cancer in humans
-
Human gastric cancer
-
Colorectal cancer
-
Human liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Human pancreatic cancer
-
Human kidney cancer
-
Human Bladder Cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer in women
-
Human Ovarian Cancer
-
Human skin cancer
-
sarcoma
-
Human Nervous System Cancer
-
Embryonal carcinoma
-
Human Lymphoma
-
Human leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other people
more -
-
Homogeneous Model
-
Homogeneous Model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Breast cancer
-
Stomach cancer
-
Liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Pancreatic cancer
-
Kidney cancer
-
Bladder cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer
-
Ovarian cancer
-
Esophageal cancer
-
Skin cancer
-
sarcoma
-
Nervous System Cancer
-
Embryonal carcinoma
-
Lymphoma
-
Leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other
-
Colorectal cancer
more -
-
News Center
——
Introducing the InnoModels Biotechnology In-Situ Modeling Platform
Author:
InnoModels
Release time:
2024-07-15
As the field of neuroscience research continues to develop and deepen, researchers' need to simulate and analyze the complex structure and function of the brain is becoming more and more urgent. In this context, with its leading brain in-situ modeling platform technology, InnoModels Biotechnology (Beijing) Co., Ltd. has provided a new breakthrough point for neuroscience research, and revolutionized the field of disease modeling, drug testing, and individualized medicine.
Brain in-situ modeling platform introduction:
InnoModels' in-situ brain model platform is a technology that utilizes state-of-the-art cell culture and tissue engineering methods to transplant human or animal brain tissue cells into an in vitro environment in the laboratory and maintain their in-situ structure and function. The platform not only simulates the natural growth environment of the brain, but also provides a realistic and complex research platform for neuroscience research by simulating the state of various neurological diseases.
Platform features:
1. In-situ structural restoration
InnoModels' in-situ brain model platform can accurately restore the in-situ structure of the brain tissue, including neuronal connections and distribution. This highly reproducible model enables researchers to better simulate and understand the complex functions of the brain, and then explore the pathogenesis and treatment of neurological diseases.
2. Disease Modeling
The platform can be used to model a variety of neurological diseases, such as Alzheimer's disease and Parkinson's disease. By simulating the pathological process of these diseases, researchers can study the pathogenesis and influencing factors of the diseases in depth and provide strong scientific support for the treatment and prevention of the diseases.

3. Drug Testing Platform
InnoModels' in situ brain modeling platform can also be used as a platform for drug testing, allowing researchers to assess the effects of new drugs on brain function and provide more accurate predictions for drug development. In addition, the platform can be combined with systemic inoculation technology to further simulate drug metabolism and immune responses in the human body, providing an important reference for the clinical application of drugs.
4. Personalized medical support
The technical characteristics of the biomimetic in situ brain model platform enable it to provide strong support for individualized medical treatment. By simulating the brain disease states of different patients, researchers can formulate more accurate treatment plans for individual differences, improving treatment effects and patients' quality of life.
Future Prospects:
With the continuous development of brain in-situ modeling technology, InnoModels will continue to drive innovation in this field. In the future, we expect to see the creation of more disease models, as well as more accurate drug testing and customized treatment plans. This technology is expected to revolutionize the field of neuroscience and thus drive neurological disease research and treatment forward.
Conclusion:
The InnoModels Biotechnology Brain In Situ Modeling Platform represents the cutting edge of neuroscience research. The application of this platform will help us understand the structure and function of the brain in a more comprehensive and in-depth way, and provide new ideas and possibilities for the treatment and prevention of neurological diseases. With the continuous development of this field, we are looking forward to the future prospects of neuroscience research.
InnoModels Biotechnology (Beijing) Co., Ltd.
-
TEL: +86 15711355061
-
E-mail: xuyl@imodels.tech
-
Address: Building 14, No. 79 West Shuangying Road, Changping District, Beijing
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.
These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.
These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.
These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.
InnoModels Biotechnology (Beijing) Co., Ltd